Blood test for high-sensitivity C-reactive protein (hs-CRP) —a marker for inflammation—is increasingly being used as a routine screening tool for patients who wonder if they are at risk of a heart attack or stroke. Easily done at the same time as a cholesterol screening & covered by most insurance. American Heart Association and American College of Cardiology both endorsed use of hs-CRP for "intermediate risk" individuals.
"We know that those with elevated hs-CRP are at high risk even if cholesterol levels are low, and that statin therapy can reduce the risk of heart attack and stroke in this group. While the JUPITER study showed inflammation contributes as much to cardiovascular risk as does high blood pressure or high cholesterol", Dr. Paul Ridker says "the core research question now is whether or not reducing inflammation per se will reduce that risk."
The ongoiing CANTOS trial will provide important information. See my SCOOP IT at http://www.scoop.it/t/heart-and-vascular-health/p/1559762525/inflammation-statin-therapy-and-hscrp-initial-observations